Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel + plinabulin vs docetaxel + pegfilgrastim for severe neutropenia
CTR20180713Phase 3Completed
- Sponsor
- BeyondSpring Inc.
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of plinabulin in neutropenia, breast cancer, non-small cell lung cancer (NSCLC), prostate cancer (PCa), sponsored by BeyondSpring Inc.. Started Jun 2018; status: completed.
02
Drugs
plinabulin
03
Conditions
neutropeniabreast cancernon-small cell lung cancer (NSCLC)prostate cancer (PCa)
Beyond the preview
Go deeper on CTR20180713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180713.